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Evaluation of a German Version of the Physical Dimensions 
of the Health Assessment Questionnaire in Patients 
with Rheumatoid Arthritis 
PIUS B R Ü H L M A N N , G E R O L D STUCKI, and BEAT A . M I C H E L 
ABSTRACT. O b j e c t i v e . Our objective was to translate and adapt the disability section of the health assessment 
questionnaire (HAQ) into German (HAQ-G) to suit Swiss-German conditions and to test its metric 
properties, reliability, and validity. 
M e t h o d s . We tested 62 consecutive patients with rheumatoid arthritis (RA) attending the outpatient 
Clinic of the Department of Rheumatology, University Hospital Zürich. A l l patients fulfilled the 
American Rheumatism Association 1987 revised criteria for R A . The translation was done by 2 
translators aware of the objective of the questionnaire and some questionable items were discussed 
and resolved in a panel by 4 rheumatologists including one bilingual clinical researcher. Test-retest 
reliability was assessed with Pearson's correlation coefficient on the scores of 2 questionnaire mailed 
in a 10-day interval. The internal consistency was assessed with Cronbach's coefficient alpha. To 
assess the construct validity, we compared the H A Q scores to clinical, laboratory, and radiological 
variables of disease activity and outcome. To assess criterion validity, we compared physicians' 
assessment of functional class (observed disability) to the H A Q (referred disability). The content 
validity was assessed in a multivariate model explaining H A Q scores with a variety of other meas-
urements of disease activity and outcome. 
Results. The test-retest reliability was 0.94; the internal consistency was 0.92; the criterion validity 
was 0.76; and correlations with other disease variables ranged from 0.39 (Larsen radiological score) 
to 0.66 (grip strength). 
C o n c l u s i o n . The H A Q - G is a reliable and valid instrument for measuring functional disability in 
a German speaking population with R A . (J R h e u m a t o l 1994;21:1245-9) 
Key I n d e x i n g Terms: 
P H Y S I C A L F U N C T I O N A L DISABILITY R H E U M A T O I D ARTHRITIS 
G E R M A N V E R S I O N H E A L T H A S S E S S E M E N T QUESTIONNAIRE 
Assessment of rheumatoid arthritis (RA) includes measure-
ments of process, prognosis, and outcome1. Outcome is the 
suffering and loss of health experienced by an individual as 
a result of the process of disease2. Death, physical disabil-
ity, discomfort, treatment side effects, and economic impact 
have been identified as primary outcome dimensions. 
Although the importance of physical disability has been 
recognized since the earliest days of the speciality of 
rheumatology3, reliable and valid measures were not deve-
loped until 19804. One of the most widely used instruments 
to measure functional disability is the Health Assessment 
Questionnaire ( H A Q ) 2 5 . It measures function in dressing, 
arising, Walking, hygiene, reaching, gripping, and in other 
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activities. The questionnaire is self-administered and may 
take less than 5 min to complete5. Its reliability and validi-
ty has been demonstrated in different languages and 
contexts5. In a number of studies, the H A Q has been shown 
to detect changes in clinical Status and it has been used as 
a primary endpoint in rheumatic disease trials6. The H A Q 
has predictive validity for work disability, resource 
utilization7, peptic ulceration8, and death5. 
We translated and adapted the disability section of the H A Q 
into German (HAQ-G) to suit Swiss-German conditions and 
tested its metric properties, reliability, and validity. 
MATERIALS AND METHODS 
Patients. We enrolled 62 consecutive patients with R A attending the rheu-
matology outpatient clinic, University Hospital, Zürich. A l l patients fulfilled 
the American Rheumatism Association (ACR) 1987 revised criteria 9 for 
the Classification of R A . 
T r a n s l a t i o n a n d c u l t u r a l a d a p t a t i o n of t h e H A Q . The primary translation 
was done by 2 translators aware of the objective of the questionnaire. The 
emphasis was to attempt the best idiomatic rather than pure vocabulary 
equivalence 1 0. A few questionable items were discussed and resolved by 
4 rheumatologists including one bilingual clinical researcher with experience 
in the use of the instrument in clinical studies, 2 with a general internal 
medicine background, and one with additional training in physical medi-
cine. The following modifications in the Swiss-German adaptation (Table 
Brühlmann, et a l : G e r m a n v e r s i o n H A Q 1 2 4 5 
Table 1. G e r m a n version of the H A Q physical disability dimension [ a l l dimensions Start 
with the question: a r e you able to ("Können S i e " ) ] 
Ankleiden und Körperpflege 
- sich selber ankleiden, Kleider zuknöpfen und Schuhe binden? 
- Ihre Haare waschen? 
Aufstehen 
- von einem Stuhl ohne Armlehne aufstehen? 
- ins Bett gehen und aufstehen? 
Eissen 
- das Fleisch mit dem Messer schneiden? 
- ein gefülltes Glas zum Munde führen? 
- einen Milchkarton (Tetrapack) öffnen? 
Gehen 
- auf ebener Strasse gehen? 
- Treppen steigen? 
Körperpf l ege 
- sich ganz waschen und abtrocknen? 
- ein Vollbad nehmen? 
- auf die Toilette gehen? 
Heben 
- einen 2 kg schweren Gegenstand (z.B. einen Sack Kartoffeln) über Kopfhöhe heben bzw. 
herunternehmen? 
- sich bücken, um ein Kleidungsstück vom Fussboden aufzuheben? 
Greifen und Öffnen 
- eine Autotüre öffnen? 
- ein Konfitürenglas öffnen, welches schon einmal offen war? 
- einen Wasserhahn auf- und zudrehen? 
Andere Tätigkeiten 
- einkaufen gehen? 
- in ein Auto ein- und aussteigen? 
- Haushaltarbeiten (z.B. Staubsaugen) oder Gartenarbeiten verrichten? 
1) were made: (a) "Cl imb up five steps" was changed to "Can you climb 
stairs"; (b) "Reach and get down a 5-pound object (such as a bag of sugar) 
from just above your head" was changed to "Can you lift and reach a 2 
kilo object above your head"; (c) the heading "gr ip" was changed to "grip 
and open"; (d) aids and devices: "walker" and "built up or special Uten-
sils" were dropped since walkers are rarely used as the only device (patients 
who need a walker have usually also a wheelchair for greater distances; 
built up or special Utensils were specified under "other"). 
with some difficulty (1), with much difficulty (2), unable to do (3). The 
highest component score in each category determines the score for the 
category unless aids or assistance are required. Dependence on equipment 
or physical assistance increases a category score of < 3 by plus I. Category 
scores are averaged to give the disability index, a value from 0 to 3. 
S c o r i n g . Scoring of questionnaires was done in accordance with the origi-
nal H A Q using the following categories (points): without any difficulty (0), 
Study d e s i g n . The questionnaire was given to the patients at a regularly sched-
uled outpatient clinic visit. The same day the patient was evaluated clini-
cally, laboratory tests were performed, and radiographs taken. The metric 
properties of the instrument and the validity were studied on this data. To 
assess the test-retest reliability the questionnaire was mailed twice with an 
1 2 4 6 The J o u r n a l of R h e u m a t o l o g y 1 9 9 4 ; 2 1 : 7 
interval of 10 days, 3 months after the cross sectional evaluation. Patients 
were therefore already familiär with the questionnaire from Time Point 1 
with the advantage of excluding a learning effect. 
R e l i a b i l i t y . The test-retest reliability was assessed with Pearson's correla-
tion coefficient. To assess the internal reliability, an analysis of internal 
consistency using Cronbacrf s coefficient alpha was performed on the overall 
scale as well as on the 3 components addressing Upper extremity function 
(eating, reach, grip) and the 3 components addressing lower extremity func-
tion (arising, Walking, activity). The relationships between the 8 compo-
nents were evaluated in a correlation matrix using Spearman's correlation 
coefficient. In a factor analysis, the loading of the 8 components and total 
interperson variability explained by the factors was studied. 
V a l i d i t y . To assess criterion validity, we correlated the H A Q (referred dis-
ability) to functional disability as recorded by the physician (observed dis-
ability) and to the A C R functional class 1991 as recently published by 
Hochberg, et a l u . 
To test the construct validity, we hypothesized a strong relationship 
between functional disability and variables of disease activity (swollen and 
tender Joint count; morning stiffhess; physicians global disease activity rated 
on a numerical rating scale; erythrocyte Sedimentation rate (ESR), C-reactive 
protein (CRP), anatomical damage (Larsen radiological score) 1 2, pain (11 
point numerical rating scale, ränge 0-10), and global health. We hypothe-
sized that grip strength (measured with a vigorimeter) would correlate most 
strongly with the grip domain and less with the other domains of the upper 
extremity and less with lower extremity domains. For Walking time we 
hypothesized that the walk domain would correlate most strongly. We also 
hypothesized that the physical disability score discriminates between patients 
with a short versus a long disease duration. For all correlations we used 
Spearman's correlation coefficients because the variables were either non-
parametric or not normally distributed. 
If the H A Q has a high content validity in reflecting the impact of the dis-
ease, different attributes of the disease process should explain important 
amounts of its variability. Thus we studied the relationship of physical dis-
ability to different aspects of the disease process in a biological multivari-
ate model. The variables for the final model were selected in a stepwise 
regression analysis of groups of variables (level to stay: p = 0.2). The fol-
lowing groups and variables were considered: demographic measures (age, 
sex), laboratory variables (ESR, CRP, thrombocytes, erythrocytes, lym-
phocytes, Singer-Plotz titer, Waaler-Rose titer, hemoglobin, iron, ferritin), 
articular indices (tender Joint count, Ritchie count, swollen Joint count), 
Performance measurement (grip), Symptoms (pain, morning stiffness), ana-
tomical damage (Larsen score), and disease duration. The variables select-
ed in the group analysis were evaluated in a stepwise selection process with 
a level to enter of 0.1 and to stay of 0.05. 
R E S U L T S 
Sixty-two patients completed the questionnaire at Time Point 
1 and 50 patients completed the questionnaire at Time Points 
2 and 3. All items were filled in, no items gave rise to mis-
understanding. The baseline characteristics of the patients 
are shown in Table 2. 
The test-retest reliability for the instrument was 0.94. The 
reliability for the categories ranged from 0.74 (grip) to 0.94 
(hygiene). The internal consistency reached an alpha of 0.92, 
the correlation of the individual items with the total ranged 
from 0.53 (walking) to 0.82 (reach). A similar high internal 
consistency (alpha = 0.92) was found for the 5 domains 
representing upper extremity functioning. The correlation 
of the domains with the average upper extremity score ranged 
from 0.74 (grip) to 0.82 (dressing). The 3 lower extremity 
domains showed a Cronbach's alpha of 0.72 and the corre-
Table 2. Baseline demographic and c l i n i c a l characteristics 
and HA Q - G scores of the 62 patients with R A 
Number of H A Q - G Score 
Patients 
(N = 62) (SD) 
Sex 
Male 23 1.1 (0.8) 
Female 39 1.1 (0.8) 
Age group 
< 49 (5.7) 15 1.1 (0.8) 
49 to 62 (7.2) 18 1.4 (0.7) 
62 to 71 (9.7) 14 0.8 (0.8) 
> 71 (10.3) 15 1.0 (0.8) 
Functional class A C R 1991 
I 9 0.1 (0.1) 
II 19 0.7 (0.7) 
III 32 1.5 (0.4) 
IV 2 2.6 (0.3) 
Rheumatoid factor (Singer Plötz) (n = 61) 
Negative 31 0.9 (0.8) 
Positive 30 1.3 (0.8) 
lation of the items with the average lower extremity score 
ranged from 0.52 (rise) to 0.56 (activity). The correlation 
matrix between the domains yielded correlation coefficients 
of 0.37 (walking and eating) to 0.78 (hygiene and reach) 
(Table 3). The principal component analysis resulted in one 
factor explaining 64% of the total variance of the scale. 
The correlation of the H A Q with the Steinbrocker scale 
was 0.6 (p < 0.01) and with the A C R 1991 functional scale 
0.76 (p < 0.01) (Table 2). The correlations between func-
tional disability and disease activity measurements, anatom-
ical damage, discomfort, and global health were all signifi-
cant (p < 0.05) and ranged from 0.39 (Larsen score) to 0.66 
(grip strength) (Table 4). Age and sex were not univariate 
correlates of the H A Q . 
The correlation of grip strength with the domains 
representing upper extremity function ranged from —0.50 
(gripping) to -0.63 (reaching) and the correlation with lower 
extremity domains from -0.29 (walking) to -0.48 
(activity). The correlation of walking time with the lower 
extremity domains ranged from 0.35 (rise) to 0.47 (Walk-
ing) and with the upper extremity domains from 0.22 (eat-
ing) to 0.49 (hygiene). 
Patients with a disease duration of < 1.5 years had a much 
lower average disability score of 0.7 than patients with a dis-
ease duration of > 11 years showing an almost doubled H A Q 
score of 1.3 on average. 
For the multivariate model, the following variables had 
univariately a p value of less than 0.2 in the group selection 
and were considered for selection: CRP, ESR, ferritin, iron, 
erythrocyte count, grip and Ritchie Joint count, Larsen score, 
pain, and morning stiffness. In the stepwise forward selec-
tion process, grip (explaining 38% of the total Variation of 
the H A Q score), morning stiffness (explaining an addition-
al 17%), ferritin (7%), CRP (4%), and Ritchie Joint count 
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Table 3. Spearman correlation coefficients among the components o f the H A Q - G 
Eating Reaching Grip Dressing Hygiene Arising * Walking Activity 
Eating 1 
Reaching 0.71 1 
Grip 0.73 0.65 1 
Dressing 0.74 0.75 0.62 1 
Hygiene 0.66 0.78 0.63 0.77 1 
Arising 0.63 0.58 0.57 0.62 0.70 1 
Walking 0.37 0.47 0.40 0.45 0.53 0.50 1 
Activity 0.64 0.69 0.66 0.59 0.64 0.50 0.50 
Table 4. Relationship of the H A Q - G score with biological 
disease variables 
Variable Median 
(Quartiles) 
Correlation with 
H A Q - G Score t 
Swollen Joint count 5 (2; 11) 0.31** 
Tender Joint count 6 (2; 15) 0.57** 
Morning stiffness (min) 15 (0; 60) 0.5** 
ESR (mm/h) 18 (12; 30) 0.26* 
C R P (mg/dl) 1.8 (0; 4, 6) 0.46** 
Activity physician (NRS* 0-10) 3 (2; 5) 0.57** 
Larsen score (ränge 0-40) 10 (8; 17, 5) 0.39** 
Grip strength (kp/cm 2) 0.6 (0.38; 0.9) -0 .66** 
Walktime (s/50 m) 32 (27; 35) 0.49** 
Global health (Likert 0-3) 2 (1; 2) 0.56** 
Pain (NRS 0-10) 5 (3; 6) 0.53** 
Disease duration (years) 5.2 (1.44; 11.6) 0.29* 
** p value < 0.01, * p value < 0.05. 
r Spearman's correlation coefficient. * NRS numerical rating scale. 
(2%) were selected. The total model r2 was 68% (p < 
0.01). 
DISCUSSION 
The adaptation of the H A Q for a Swiss-German context 
required no major cultural adaptation since the cultural 
similarity is high. Because German and English are linguis-
tic relatives, most items could be translated with vocabulary 
equivalence. Few questions required a different phrasing to 
avoid misunderstanding and to guarantee idiomatic 
equivalence. 
The metric properties of the H A Q - G were similar to those 
presented in the original report2 and in other adaptations5. 
The internal consistency was high and indicates that the com-
ponents of the scale measure the same construct. The items 
correlated all with each other, but there was no redundan-
cy; this indicates that each domain addresses a somewhat 
different aspect of functional disability. The test-retest relia-
bility was similar to reported evaluations which reported 
correlations between 0.87 and 0.965. The high correlation 
with other measurements of functional disability such as the 
Steinbrocker functional scale and even more with the recently 
developed A C R functional class 1991 demonstrates that both 
instruments measure a similar construct. As expected, we 
found strong correlations with variables of disease activity 
as well as Joint destruction. This is consistent with the con-
cept that functional disability is influenced by process as well 
as destruction and may explain why grip strength, another 
combined measurement of both dimensions, was the strongest 
correlate. 
The finding that 68% of the Variation of the H A Q - G can 
be explained by a few biological variables reflects the strong 
relationship between disease process and functional disabil-
ity. Since heterogeneous dimensions of the disease includ-
ing laboratory variables and signs and Symptoms explained 
relevant proportions of the variability of the H A Q - G , it can 
be concluded that this concept of functional disability com-
prehensively addresses the impact of RA. The responsive-
ness of the scale has not yet been studied in this Validation. 
However, the sensitivity of the H A Q has been demonstrated 
in multiple studies using the original version as well as other 
cross cultural adaptations. Since we were able to demonstrate 
the similarity of the instrument with respect to metric proper-
ties, reliability, and validity, we expect a similar responsive-
ness for this German version of the H A Q . 
We conclude that the German version of the H A Q retains 
the characteristics of the American original and is a reliable 
and valid instrument to measure functional disability in 
German speaking patients with RA. 
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